ELEANOR KURTH: Open Payments
NPI 1881320869 · DAVENPORT, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$774 in 32 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $202 · 2025 $774
Food & beverage: $674Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $300 |
| Janssen Biotech, Inc. | 5 | $177 |
| UCB, Inc. | 11 | $139 |
| Amgen Inc. | 2 | $48 |
| Novartis Pharmaceuticals Corporation | 2 | $39 |
| GlaxoSmithKline, LLC. | 1 | $25 |
| Radius Health, Inc. | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: RINVOQ, TREMFYA, Bimzelx, COSENTYX, SKYRIZI, ENBREL, BENLYSTA, TAVNEOS.
Industry payments across IA — which companies pay providers there.
